HomeCompareMEDX vs NOBL

MEDX vs NOBL: Dividend Comparison 2026

MEDX yields 1.24% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NOBL wins by $1.4K in total portfolio value
10 years
MEDX
MEDX
● Live price
1.24%
Share price
$33.04
Annual div
$0.41
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$134.07
Full MEDX calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — MEDX vs NOBL

📍 NOBL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMEDXNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MEDX + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MEDX pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDX
Annual income on $10K today (after 15% tax)
$105.17/yr
After 10yr DRIP, annual income (after tax)
$113.96/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, NOBL beats the other by $95.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDX + NOBL for your $10,000?

MEDX: 50%NOBL: 50%
100% NOBL50/50100% MEDX
Portfolio after 10yr
$22.1K
Annual income
$190.12/yr
Blended yield
0.86%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDX buys
0
NOBL buys
0
No recent congressional trades found for MEDX or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMEDXNOBL
Forward yield1.24%2.14%
Annual dividend / share$0.41$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$21.4K$22.8K
Annual income after 10y$134.07$246.19
Total dividends collected$1.3K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: MEDX vs NOBL ($10,000, DRIP)

YearMEDX PortfolioMEDX Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$10,824$123.73$10,914$214.34$90.00NOBL
2$11,707$125.16$11,897$218.63$190.00NOBL
3$12,653$126.51$12,952$222.72$299.00NOBL
4$13,666$127.79$14,086$226.62$420.00NOBL
5$14,752$129.00$15,302$230.33$550.00NOBL
6$15,914$130.13$16,607$233.85$693.00NOBL
7$17,160$131.21$18,007$237.18$847.00NOBL
8$18,493$132.22$19,508$240.35$1.0KNOBL
9$19,921$133.17$21,116$243.35$1.2KNOBL
10$21,449$134.07$22,841$246.19$1.4KNOBL

MEDX vs NOBL: Complete Analysis 2026

MEDXStock

The Horizon Kinetics Medical ETF seeks long-term growth of capital by investing primarily in patented first line pharmaceuticals and biologics, aiming to capture returns from intrinsic valuation realization and scientific discovery.

Full MEDX Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this MEDX vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDX vs SCHDMEDX vs JEPIMEDX vs OMEDX vs KOMEDX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.